STATCenter·
STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?
Read at STAT →
Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?

<iframe src="https://statesidedaily.com/embed/cluster/9dc084aea830df58a93ef23d385b0ae7e0e85952" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial"></iframe>